Are you Dr. El-Osta?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 46 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
6400 Fannin St
Suite 2900
Houston, TX 77030Phone+1 832-325-7702Fax+1 713-512-7132
Summary
- Dr. Hazem El-Osta, MD is an oncologist in Houston, Texas. He is currently licensed to practice medicine in Texas and Louisiana. He is affiliated with Memorial Hermann - Texas Medical Center and is an Assistant Professor at LA State Univ Sch of Med.
Education & Training
Louisiana State University School of MedicineFellowship, Hematology and Medical Oncology, 2010 - 2013
University of Kansas (Wichita)Residency, Internal Medicine, 2006 - 2009
St Joseph's University Medical SchoolClass of 2004
Certifications & Licensure
LA State Medical License 2010 - 2025
TX State Medical License 2016 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches Start of enrollment: 2014 Nov 01
- Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Sep 01
- Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers Start of enrollment: 2015 Dec 29
Publications & Presentations
PubMed
- Erratum to "Brief Report: Canadian Cancer Trials Group IND.227: A Phase II randomized study of pembrolizumab in patients with advanced malignant pleural mesothelioma (...Maria Carmela Piccirillo, Quincy Chu, Penelope Bradbury, Wei Tu, Courtney H Coschi
Journal of Thoracic Oncology. 2024-11-01 - 10 citationsBrief Report: Canadian Cancer Trials Group IND.227: A Phase 2 Randomized Study of Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma (NCT02784171).Maria Carmela Piccirillo, Quincy Chu, Penelope Bradbury, Wei Tu, Courtney H Coschi
Journal of Thoracic Oncology. 2023-06-01 - 10 citationsReal-World Time on Treatment with First-Line Pembrolizumab Monotherapy for Advanced NSCLC with PD-L1 Expression ≥ 50%: 3-Year Follow-Up Data.Vamsidhar Velcheti, Xiaohan Hu, Yeran Li, Hazem El-Osta, M Catherine Pietanza
Cancers. 2022-02-18
Other Languages
- French, Arabic
